The DENOCHARCOT Trial
The aim of the present trial is to assess the efficacy of treatment of acute Charcot foot in diabetes patients with Prolia® on clinical relevant Outcomes in a randomized, double blind, placebo-controlled trial.
Age 18-80 years [+3]
Duration of the acute Charcot foot for more than 3 months (at the screening visi... [+23]